|
|
||||||||
From the Institut National de la Santé et de la Recherche Médicale U360 (Drs. Dufouil, Besançon, Alpérovitch, and Tzourio), Hôpital la Salpêtrière, Paris; the Department of Radiology (Drs. de KersaintGilly and Auffray), Laënnec Hospital, Nantes; the Department of Radiology (Dr. Levy), Institut Hospitalier Jacques Cartier, Massy; and the Department of Radiology (Dr. Brunnereau), Hôpital Saint-Antoine, Paris, France.
Address correspondence and reprint requests to Dr. Carole Dufouil, INSERM U360, Hôpital La Salpêtrière, 75651 Paris Cédex 13, France; e-mail: carole.dufouil{at}chups.jussieu.fr
OBJECTIVE: To investigate the relationship between baseline hypertension and severity of white matter hyperintensities (WMH) at 4-year follow-up in a sample of subjects aged 59 to 71 years old at entry.
METHODS: Subjects were participants in the Epidemiology of Vascular Ageing study, a longitudinal study on vascular aging and cognitive decline. At 4-year follow-up, 845 subjects had a cerebral MRI. MRI examinations were read by a single rater to determine the severity of WMH, ranging from absent to severe. Hypertension at each wave of the study was defined as systolic blood pressure
160 mm Hg, diastolic blood pressure
95 mm Hg, or use of antihypertensive medication.
RESULTS: Hypertension at baseline was significantly associated with an increased risk of having severe WMH at 4-year follow-up. When taking into account both blood pressure levels and antihypertensive drug intake, analysis showed that the risk of having severe WMH was significantly reduced in subjects with normal blood pressure taking antihypertensive medication compared with those with high blood pressure taking antihypertensive agents. Cross-sectional relationships between hypertension and WMH at 4-year follow-up showed that the frequency of severe WMH was significantly higher in people who were hypertensive at both baseline and 4-year follow-up than those who were hypertensive only at 4-year follow-up.
CONCLUSIONS: Hypertension is a major risk factor for severe WMH. Subjects taking antihypertensive drugs and who have controlled blood pressure had a reduced risk of severe WMH. Longitudinal studies are needed to investigate whether reduction of the development of WMH, by treatment and prevention of hypertension, might reduce the subsequent risk of cognitive deterioration or stroke.
This article has been cited by other articles:
![]() |
X. Guo, L. Pantoni, M. Simoni, C. Bengtsson, C. Bjorkelund, L. Lissner, D. Gustafson, and I. Skoog Blood Pressure Components and Changes in Relation to White Matter Lesions: A 32-Year Prospective Population Study Hypertension, July 1, 2009; 54(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Srikanth, R. Beare, L. Blizzard, T. Phan, J. Stapleton, J. Chen, M. Callisaya, K. Martin, and D. Reutens Cerebral White Matter Lesions, Gait, and the Risk of Incident Falls: A Prospective Population-Based Study Stroke, January 1, 2009; 40(1): 175 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Insel, S. L. Reminger, and C.-P. Hsiao White Matter Hyperintensities and Medication Adherence Biol Res Nurs, October 1, 2008; 10(2): 121 - 127. [Abstract] [PDF] |
||||
![]() |
Y. I. Sheline, J. L. Price, S. N. Vaishnavi, M. A. Mintun, D. M. Barch, A. A. Epstein, C. H. Wilkins, A. Z. Snyder, L. Couture, K. Schechtman, et al. Regional White Matter Hyperintensity Burden in Automated Segmentation Distinguishes Late-Life Depressed Subjects From Comparison Subjects Matched for Vascular Risk Factors Am J Psychiatry, April 1, 2008; 165(4): 524 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Stewart, B. S. Schwartz, C. Davatzikos, D. Shen, D. Liu, X. Wu, A. C. Todd, W. Shi, S. Bassett, and D. Youssem Past adult lead exposure is linked to neurodegeneration measured by brain MRI Neurology, May 23, 2006; 66(10): 1476 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin Blood Pressure Lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and White Matter Hyperintensities: Should This Progress Matter to Patients? Circulation, September 13, 2005; 112(11): 1525 - 1526. [Full Text] [PDF] |
||||
![]() |
C. Dufouil, J. Chalmers, O. Coskun, V. Besancon, M.-G. Bousser, P. Guillon, S. MacMahon, B. Mazoyer, B. Neal, M. Woodward, et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy Circulation, September 13, 2005; 112(11): 1644 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Goldstein, G. Bartzokis, D. Guthrie, and D. Shapiro Ambulatory blood pressure and the brain: A 5-year follow-up Neurology, June 14, 2005; 64(11): 1846 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Birns, H. Markus, and L. Kalra Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid? Stroke, June 1, 2005; 36(6): 1308 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Staessen and W. H. Birkenhager Cognitive Impairment and Blood Pressure: Quo Usque Tandem Abutere Patientia Nostra? Hypertension, November 1, 2004; 44(5): 612 - 613. [Full Text] [PDF] |
||||
![]() |
P. K. Elias, M. F. Elias, M. A. Robbins, and M. M. Budge Blood Pressure-Related Cognitive Decline: Does Age Make a Difference? Hypertension, November 1, 2004; 44(5): 631 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. van Dijk, M. M.B. Breteler, R. Schmidt, K. Berger, L.-G. Nilsson, M. Oudkerk, A. Pajak, S. Sans, M. de Ridder, C. Dufouil, et al. The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions: Cardiovascular Determinants of Dementia Study Hypertension, November 1, 2004; 44(5): 625 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kuo and L. A. Lipsitz Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link? J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M818 - M826. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmidt, L. J. Launer, L.-G. Nilsson, A. Pajak, S. Sans, K. Berger, M. M. Breteler, M. de Ridder, C. Dufouil, R. Fuhrer, et al. Magnetic Resonance Imaging of the Brain in Diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study Diabetes, March 1, 2004; 53(3): 687 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension, December 1, 2003; 42(6): 1206 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Taylor, D. C. Steffens, J. R. MacFall, D. R. McQuoid, M. E. Payne, J. M. Provenzale, and K. R. R. Krishnan White Matter Hyperintensity Progression and Late-Life Depression Outcomes Arch Gen Psychiatry, November 1, 2003; 60(11): 1090 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Taylor, J. R. MacFall, J. M. Provenzale, M. E. Payne, D. R. McQuoid, D. C. Steffens, and K. R. R. Krishnan Serial MR Imaging of Volumes of Hyperintense White Matter Lesions in Elderly Patients: Correlation with Vascular Risk Factors Am. J. Roentgenol., August 1, 2003; 181(2): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Wardlaw, P.A.G. Sandercock, M.S. Dennis, J. Starr, and H. Kalimo Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? Stroke, March 1, 2003; 34(3): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Tzourio, B Gagniere, M El Amrani, M-G Bousser, and A Alperovitch Lay versus expert interviewers for the diagnosis of migraine in a large sample of elderly people J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 238 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Wong, R. Klein, A. R. Sharrett, D. J. Couper, B. E. K. Klein, D.-P. Liao, L. D. Hubbard, T. H. Mosley, and for the ARIC Investigators Cerebral White Matter Lesions, Retinopathy, and Incident Clinical Stroke JAMA, July 3, 2002; 288(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.R. Marstrand, E. Garde, E. Rostrup, P. Ring, S. Rosenbaum, E.L. Mortensen, and H.B.W. Larsson Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities Stroke, April 1, 2002; 33(4): 972 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-E. de Leeuw, J. C. de Groot, M. Oudkerk, J. C. M. Witteman, A. Hofman, J. van Gijn, and M. M. B. Breteler Hypertension and cerebral white matter lesions in a prospective cohort study Brain, March 1, 2002; 125(4): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |